# Sotatercept in Pulmonary Arterial Hypertension

> **NCT07140484** · PHASE4 · RECRUITING · sponsor: **University of Alberta** · enrollment: 27 (estimated)

## Conditions studied

- Pulmonary Artery Hypertension

## Interventions

- **DRUG:** Sotatercept

## Key facts

- **NCT ID:** NCT07140484
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-06
- **Primary completion:** 2029-01-01
- **Final completion:** 2030-01-01
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07140484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07140484, "Sotatercept in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07140484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*